Glenmark Life Sciences IPO GMP TODAY (LIVE DATA) Latest Grey Market Premium Updates

Glenmark Life Sciences IPO GMP Today, Glenmark Life Sciences IPO Grey Market Premium Updates | Glenmark Life Sciences IPO Listing Gain, Latest target, Opening gain

Glenmark Life Sciences Ltd initial public offer (IPO) is set to open for subscription on July 27 and close on July 29, after it received capital market regulator Sebi’s go-ahead to raise Rs 1513.60 crore through public issue.

Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.

Check out Glenmark Life Sciences IPO grey market premium, Kostak rates, and subject to sauda rates as of today.

Glenmark Life Sciences IPO Details:

Issuer Glenmark Life Sciences Ltd
Issue Type Book Built Issue IPO
Issue Period Issue Opens: July 27, 2021
Issue Closes: July 29, 2021
Price Brand ₹695 to ₹720 Per Share
Issue Size ₹1513.60 Crores
Face Value Rs. 2 per Equity Share
Market Lot 20 Shares
Maximum Bid amount for Retail Rs. 2 Lakhs
QIB 50% of the issue size
NIB 15% of the issue size
Retail Individual Bidders 35% of the issue size
Fresh Issue ₹ 1060 Cr
Offer for Sale ₹ 453.60 Cr
Listing at NSE & BSE
Apply With Upstox Free DEMAT Account
Equity 6,300,000 Shares
Grey Market Price Glenmark Life Sciences IPO GMP Today



Glenmark Life Sciences IPO Review


Glenmark Life Sciences IPO GMP Rates day by day

Glenmark Life Sciences IPO Grey market premium as on today

Date GMP (in INR) Kostak (in INR) Subject to Sauda
06 AUG 2021
05 AUG 2021 90
04 AUG 2021 81
03 AUG 2021 81
02 AUG 2021 91
01 AUG 2021 100
31 July 2021 130
30 July 2021 138 2000
29 July 2021 130 300 1500
28 July 2021 120 300 1500
27 July 2021 101 300 1500
26 July 2021 125
25 July 2021 130
24 July 2021 128 300 4000
23 July 2021 190 400 3000
22 July 2021 210 350 4000
21 July 2021 205 400 4000

How to Apply for Glenmark Life Sciences IPO :

If you’re a new investor Open DEMAT Account for free with Angel Broking and build wealth with the best stock choices. Join 1 million+ family of happy customers.

In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.

Glenmark Life Sciences IPO Market Lot:

 Lot Size:  Minimum 20 Shares & Maximum 260 Shares
 Minimum Amount:  ₹14400
 Maximum Amount: ₹187200

Glenmark Life Sciences IPO Allotment & Listing:

 Basis of Allotment: AUG 03, 2021
 Refunds: AUG 04, 2021
 Credit to Demat Account: AUG 05, 2021
 Listing Date: AUG 06, 2021

Check:- Tatva Chintan Pharma IPO Allotment Status


– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies.
– This is only coverage of News related to Grey Market . We don’t deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

IPO GMP rates are provided as sourced from market intelligence. Please note these IPO GMP rates may be different depending on geographies and markets.

We don’t trade into grey market nor do we facilitate buying or selling of IPO forms.

What is Grey Market?

Grey Market is the term used to describe unregulated over-the-counter market for trading IPO applications and IPO shares before the stock is listed at a stock market. This is a way for dealers to support their customers who may want to exit before listing.

This is also a way to boost the listing price and support the issue before listing happens. There are two kinds of transactions that happen in thee IPO grey market:

  • Trade of IPO shares at a grey market premium
  • Trade of IPO application at a kostak.

What is Grey Market Premium?

GMP or Grey Market Premium is the premium at which equity shares from the IPO are being traded in the grey market.

This could either be a positive or negative – meaning the trading price in the grey market is either higher or lower than issue price respectively, based on demand and supply for the shares.

Typically, investors who do not want to take the risk of allocation not happening through IPO will buy shares in the gray market and hope to flip the shares on listing to make a good profit.

What is Kostak?

Kostak is the premium at which IPO application is being traded in the grey market. Applications are typically traded after the application window is closed but the allotment has not yet been finished.

It is rare for someone to trade IPO application post-allocation. This is a way for investors to increase their chance of shares being allotted as the allocation process treats each retail application equally. An example (indicative) for kostak is:


Glenmark Life Sciences Limited
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720

This means Glenmark Life Sciences applications of Rs 14400 are being traded in IPO Grey Market at Rs 695 to Rs 720.

Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.

As can be seen the Kostak is at a much lower %age than GMP. This indicates that the grey market expects the issue to be oversubscribed and expects on an average only one lot to be allocated per application.

Kostak rate is the amount an investor gets by selling his/her IPO application in grey market. This is the amount an investor stands to gain, irrespective of allotment status.

Subject to Sauda simply reflects the amount which an investor stands to get by selling his/her application for firm allotment. The key operative word here is firm allotment. In case of no allotment to the applicant, the sauda stands cancelled.

In case of ‘Subject to Sauda’ deal, while selling IPO application in the grey market, buyer and seller agree that deal is only valid if the seller will get the allotment. If the seller doesn’t get any shares in IPO process, the deal gets avoid.